OTCBB ALERTS

[ProfitScout]

$AVRW management has given positive guidance for the upcoming Q3 report. Sales of the company's increasingly popular Seratopical product line are on an improving growth curve. This trend should become more evident as all future financial reports are posted.
--------------------------------------------------------------------------------------------------------
"...we are encouraged by the early results and accelerating sales heading into the third quarter, which reaffirms the improving overall trajectory of the business. As mentioned in our first quarter earnings announcement, the proceeds from the July 2022 asset sale allowed us to invest in the future of the Company, but the delay in receiving the balance of the proceeds versus our expectations had a negative impact on our second quarter performance. Our margin expansion initiatives continue to deliver results, and we are moving forward with our efforts to further reduce SG&A expenses and to maximize operating leverage.

We are also very excited by the continued success of the advertising and marketing campaigns for our Seratopical Revolution product line. theSkimm continues to deliver as we execute on our strategy to build our brands," said Nancy Duitch, Avenir CEO.
Source:
https://www.accesswire.com/774208/avenir-wellness-solutions-reports-second-quarter-2023-results